NUTRALIFE BIOSCIENCES, INC Quarterly Operating Income (Loss) in USD from Q1 2014 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Nutralife Biosciences, Inc quarterly/annual Operating Income (Loss) history and growth rate from Q1 2014 to Q3 2022.
  • Nutralife Biosciences, Inc Operating Income (Loss) for the quarter ending September 30, 2022 was -$445K, a 17.5% increase year-over-year.
  • Nutralife Biosciences, Inc Operating Income (Loss) for the twelve months ending September 30, 2022 was -$2.44M, a 48.4% increase year-over-year.
  • Nutralife Biosciences, Inc annual Operating Income (Loss) for 2021 was -$4.47M, a 127% decline from 2020.
  • Nutralife Biosciences, Inc annual Operating Income (Loss) for 2020 was -$1.97M, a 41.9% increase from 2019.
  • Nutralife Biosciences, Inc annual Operating Income (Loss) for 2019 was -$3.4M, a 78.1% decline from 2018.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 -$2.44M -$445K +$94.6K +17.5% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-21
Q2 2022 -$2.53M -$650K +$40.7K +5.89% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-22
Q1 2022 -$2.57M -$728K +$1.9M +72.3% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-23
Q4 2021 -$4.47M -$615K +$249K +28.8% Oct 1, 2021 Dec 31, 2021 10-K 2022-04-11
Q3 2021 -$4.72M -$540K -$101K -23% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-21
Q2 2021 -$4.62M -$691K -$526K -320% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-22
Q1 2021 -$4.09M -$2.63M -$2.12M -419% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-23
Q4 2020 -$1.97M -$863K +$134K +13.4% Oct 1, 2020 Dec 31, 2020 10-K 2022-04-11
Q3 2020 -$2.11M -$439K +$431K +49.5% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$2.54M -$164K +$370K +69.2% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 -$2.91M -$506K +$488K +49.1% Jan 1, 2020 Mar 31, 2020 10-Q 2021-07-16
Q4 2019 -$3.4M -$997K -$614K -160% Oct 1, 2019 Dec 31, 2019 10-K 2021-06-24
Q3 2019 -$2.78M -$870K -$188K -27.5% Jul 1, 2019 Sep 30, 2019 10-Q 2021-05-12
Q2 2019 -$2.59M -$534K -$308K -136% Apr 1, 2019 Jun 30, 2019 10-Q 2021-04-22
Q1 2019 -$2.29M -$994K -$380K -61.8% Jan 1, 2019 Mar 31, 2019 10-Q 2021-04-12
Q4 2018 -$1.91M -$383K +$43.8K +10.3% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-19
Q3 2018 -$1.95M -$682K +$7.85M +92% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 -$9.79M -$226K +$9.95M +97.8% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-19
Q1 2018 -$19.7M -$614K +$3.88M +86.3% Jan 1, 2018 Mar 31, 2018 10-Q/A 2019-05-17
Q4 2017 -$23.6M -$427K Oct 1, 2017 Dec 31, 2017 10-K/A 2019-04-03
Q3 2017 -$8.53M Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 -$10.2M Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 -$4.49M Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-21
Q3 2015 -$2.54M -$780K -$280K -56.1% Jul 1, 2015 Sep 30, 2015 10-Q 2015-12-17
Q2 2015 -$2.26M -$501K +$37.5K +6.96% Apr 1, 2015 Jun 30, 2015 10-Q 2015-09-04
Q1 2015 -$2.3M -$502K -$222K -79.3% Jan 1, 2015 Mar 31, 2015 10-Q 2015-05-15
Q4 2014 -$2.08M -$757K Oct 1, 2014 Dec 31, 2014 10-K/A 2015-04-29
Q3 2014 -$500K Jul 1, 2014 Sep 30, 2014 10-Q 2015-12-17
Q2 2014 -$538K Apr 1, 2014 Jun 30, 2014 10-Q 2015-09-04
Q1 2014 -$280K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.